Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2006 - 2009
- New York University School of MedicineClass of 2006
- Brandeis UniversityBA, Biology, Magna Cum Laude, 1998 - 2002
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2024 - 2026
- TN State Medical License 2024 - 2026
- TX State Medical License 2017 - 2026
- GA State Medical License 2024 - 2025
- LA State Medical License 2024 - 2025
- MS State Medical License 2024 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Awards, Honors, & Recognition
- Henry L. Moses Award in Basic Science Montefiore Medical Center, 2014
- Lewis Fraad Award for Excellence in Teaching of Residents Children’s Hospital at Montefiore, 2013
- Pediatric Research Day Poster Presentation Award Albert Einstein College of Medicine, 2012
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsInitial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing ConsortiumDouglas J. Harrison, Jonathan D. Gill, Michael Roth, Wendong Zhang, Beverly A. Teicher
Pediatric Blood & Cancer. 2020-03-24 - 94 citationsMinimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O. Vogler, Swathi Rao Narayanagari, Boris Bartholdy, Tihomira I. Todorova
Nature Medicine. 2015-10-01 - 2 citationsA systematic review and meta-analysis of e-cigarette use among cancer survivors.Maria A Lopez-Olivo, Justin James, Joel James, Kate J Krause, Michael Roth
Journal of Cancer Survivorship. 2024-06-01
Journal Articles
- Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in OsteosarcomaRoth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R, Cancer, 1/1/2014
- Screening for maternal depression in a low education population using a two item questionnaireCutler C, Legano L, Dreyer B, Fierman a, Berkule S, Lusskin S, Tomopoulos S, Roth M, Mendelsohn A, Archive of Women's Mental Health, 1/1/2007
Books/Book Chapters
Abstracts/Posters
- Prenatal Hemoglobinopathy Screening Practices: Areas for ImprovementMichael E. Roth, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Communicating prognosis in sickle cell disease: addressing the future to facilitate informed decisions.Pecker L, Roth M, Landman S, Cunnigham L, Johnson E, Manwani D, Sickle Cell Disease Society of America, Baltimore, MD, 9/1/2014
- Delivering bad news: The use of standardized patient encounters to improve communication skills in pediatric oncology fellows.Weintraub L, Figueiredo L, Roth M, Levy A, Poster presentation, Davidoff Education Day, Albert Einstein College of Medicine, 3/1/2014
- Join now to see all
Lectures
- Career Development and Goal Setting: Invited Speaker.Albert Einstein College of Medicine - 7/1/2014
- Approach to Anemia.4/1/2014
- Oncologic Emergencies.Children's Hospital at Montefiore, Bronx, NY - 1/1/2014
- Join now to see all
Press Mentions
- Cancer Survival Rates Rose for Young Adults After Affordable Care ActOctober 8th, 2024
- Why More People Under Age 40 Are Being Diagnosed with CancerMay 24th, 2022
- MD Anderson to Launch Cancer Survivorship Training for PCPsJuly 4th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: